Endocrine Abstracts

Methods: This study, was a cross-sectional survey. Sampling design was based upon multistage probability sampling. Patient with diabetes, hypertension, cardiovascular diseases and any other diseases were excluded from the study. Age and gender were noted. Heights, weights and waist circumference (WC) were measured. BMI was calculated. Blood pressure (BP) was measured. Fasting thyrigliseride levels were evaluated. Patients were divided into two groups according to their triglyceride levels (TG <150 mg/dl and TG >150 mg/dl.

Results: 344 participants were screened for the study, 224 of them had normotriglyceridemia, 120 of them had hypertriglyceridemia. 38.5% of participants were male, and 61.5% was female. Mean age was 48.76±14.08 years. Mean values were; WC 91.14±13.54 cm, BMI 28.42±5.87 kg/m²,systolic BP 131.74±25.62 mm/Hg, diastolic BP 81.05±15.17 mm/Hg in normotriglyceridemia group. Mean values were; WC 94.85±11.83 cm, BMI 29.02±5.15 kg/m², systolic BP 140.08±23.65 mm/Hg, diastolic BP 87.46±16.89 mm/Hg in hypertriglyceridemia group. Except BMI the other variables were significantly higher in the hypertriglyceridemia group (P<0.04). BMI was similar in each groups.

Conclusion: Present study showed that without any comorbidities hyperthyrigliceridemia was a risk factor of hypertension. High BP, increased WC, hypertrigliceridemia were ATP III metabolic syndrome criterias. Metabolic syndrome is associated with increased risk for cardiovascular disease.